Supply Chain Latest News news and information

ICU Medical, the San Clemente, Calif.-based producer of intravenous medical equipment, is weighing a sale that may fetch more than $1 billion, said people familiar with the matter. The shares rose to their highest closing price since first being sold to the public 21 years ago.
FULL STORY »

It's likely to be another seven weeks before the Food and Drug Administration finalizes long-awaited regulations that will require manufacturers to mark medical devices with unique identifiers that are expected to help track products during recalls, save money and improve patient safety.
FULL STORY »

The CVS drugstore chain is getting out of the business of using its data from patient prescription drug records to mail prescription refill notices to customers on behalf of pharmaceutical manufacturers, citing as a reason for the policy change a more stringent provision of the omnibus privacy rule...
FULL STORY »

The head of Europe's medicines regulator is digging in for a fight over data transparency after being stopped from releasing information on drugs from two U.S. companies by a court ruling.
FULL STORY »

A study of conflicts of interest in leading cancer journals showed financial connections between authors and companies sponsoring phase 3 clinical trials had little impact on interpretation of the results.
FULL STORY »

German drug company Bayer says it has agreed to buy California-based Conceptus for around $1.1 billion to expand the kinds of birth control it offers.
FULL STORY »

In an effort to find a treatment for autism, scientists at the University of California, Los Angeles, are leading a $9 million experiment that aims to evaluate the effectiveness of drugs within weeks rather than years.
FULL STORY »

Novartis, the Swiss drugmaker already under a strict corporate-integrity agreement because of a past settlement, was targeted by two lawsuits last week by the U.S. attorney's office for New York City alleging widespread payments of illegal kickbacks.
FULL STORY »

A new draft bill would establish different regulations for traditional compounding pharmacies and what the legislation is calling “compounding manufacturers,” the large-scale compounders that mix and ship sterile drugs across state lines.
FULL STORY »

CareFusion Corp., the publicly traded devicemaker spun off from Cardinal Health, announced that it will enter into an agreement with federal investigators to pay $41 million and avoid criminal prosecution for its past sales and marketing of antiseptic surgical wipes.
FULL STORY »